Published 2007-06-15
license
Article (before OJS)

Comparison in the Handling of Patients With Mitral Mixomatosa Degeneration With Enalapril or With the Combination Enalapril Spironolactone

DOI: https://doi.org/10.22490/24629448.372
Leonardo Gómez Unidad de medicina y cirugía cardiovascular. Programa de Medicina Veterinaria. Universidad Antonio Nariño. Bogotá, Colombia
Mauricio Ortega Unidad de medicina y cirugía cardiovascular. Programa de Medicina Veterinaria. Universidad Antonio Nariño. Bogotá, Colombia
The behavior of 45 canine patients with degeneration to valvular mixomatosa mitral, handled with a combination enalapril- espironolactona (20) or enalapril (25) were evaluated in three occasions during 12 months, making a pursuit of survival, serum levels of aldosterone (marking), creatinine, ureico nitrogen in blood, sodium and potassium.

It was observed that aldosterone has a reduction in the serum levels subsequent to the treatment with enalapril and espironolactona far beyond the treated solely with enalapril, but in the last evaluation, they increase the levels over the initial values, which suggests they already have activated other routes for the synthesis from the aldosterone, which are not mediated by angiotensin II and therefore they do not respond suitably to converter enzymes of angiotensin. The benefit of the combination with espironolactone is based on its selective blocking a selective of the aldosterone receivers, which would diminish its lethal action on the myocardium and the blood vessels.

keywords: aldosterone, angiotensin, degeneration to valvular myxomatosa, enalapril, fails cardiac, vasoconstriction
license
How to Cite
Gómez, L., & Ortega, M. (2007). Comparison in the Handling of Patients With Mitral Mixomatosa Degeneration With Enalapril or With the Combination Enalapril Spironolactone. NOVA Biomedical Sciences Journal, 5(7), 42-47. https://doi.org/10.22490/24629448.372
Almétricas
Metrics
Archivos descargados
523
Jul 2007Jan 2008Jul 2008Jan 2009Jul 2009Jan 2010Jul 2010Jan 2011Jul 2011Jan 2012Jul 2012Jan 2013Jul 2013Jan 2014Jul 2014Jan 2015Jul 2015Jan 2016Jul 2016Jan 2017Jul 2017Jan 2018Jul 2018Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20269
|

PRIVACY STATEMENT: In accordance with the Personal Data Protection Law (Law 1581 of 2012), the names and email addresses managed by Revista NOVA will be used exclusively for the purposes stated by this journal and will not be made available for any other purpose or to any other individual. Manuscripts submitted to the publication are only accessible to the editorial team and external peer reviewers.

Design and implemented by